✦ LIBER ✦

Optimizing TNFα antagonist therapy in patients with spondyloarthritis: Why and how?

✍ Scribed by Daniel Wendling; Clément Prati; Philippe Goupille; Denis Mulleman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of TNFα antagonist t

✍ Moana Sulpice; Chantal Job Deslandre; Pierre Quartier 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 153 KB

TNFα antagonist therapy in patients with

✍ Daniel Wendling; Georges Herbein 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Effect of discontinuing TNFα antagonist

✍ Olivier Brocq; Elodie Millasseau; Christine Albert; Christian Grisot; Philippe F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Aseptic osteomyelitis responding to TNFα

✍ Johan Bret; Olivia Lemaire; Catherine Prat; Laurent Zabraniecki; Bernard Fournie 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 626 KB

Recommendations of the French Society fo

✍ Bruno Fautrel; Thao Pham; Gaël Mouterde; Xavier Le Loët; Philippe Goupille; Fran 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Serum levels of MMP-3 and cathepsin K in

✍ Daniel Wendling; Jean-Pierre Cedoz; Evelyne Racadot 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 121 KB